Adult and Pediatric Vaccines Market Report

Global and Region Adult and Pediatric Vaccines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：190
  • REPORT CODE：GMM1003054
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

    The report details the trend, potential and market size of Adult and Pediatric Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Adult and Pediatric Vaccinesmarket, defines the market attractiveness level of Adult and Pediatric Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Adult and Pediatric Vaccines industry, describes the types of Adult and Pediatric Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Adult and Pediatric Vaccines market and the development prospects and opportunities of Adult and Pediatric Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Adult and Pediatric Vaccines market in Chapter 13.

    By Player:

    • Emergent BioSolutions, Inc (US)

    • Mitsubishi Tanabe Pharma Corporation (Japan),

    • GlaxoSmithKline plc (UK)

    • Daiichi Sankyo Company, Limited (Japan)

    • Serum Institute of India Pvt Ltd (India)

    • Pfizer, Inc (US)

    • Bavarian Nordic (Denmark)

    • Merck & Co, Inc (US)

    • Johnson & Johnson (US)

    • CSL Limited (Australia)

    • Sanofi Pasteur (France)

    • AstraZeneca (UK)

    By Type:

    • Adult Vaccines

    • Pediatric Vaccines

    By End-User:

    • Hospitals

    • Medical Care Centers

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Adult and Pediatric Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Adult and Pediatric Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Adult and Pediatric Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Adult and Pediatric Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Adult and Pediatric Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Adult and Pediatric Vaccines Consumption (2017-2022)

    • 7.2 United States Adult and Pediatric Vaccines Consumption (2017-2022)

    • 7.3 Europe Adult and Pediatric Vaccines Consumption (2017-2022)

    • 7.4 China Adult and Pediatric Vaccines Consumption (2017-2022)

    • 7.5 Japan Adult and Pediatric Vaccines Consumption (2017-2022)

    • 7.6 India Adult and Pediatric Vaccines Consumption (2017-2022)

    • 7.7 South Korea Adult and Pediatric Vaccines Consumption (2017-2022)

    8 Region and Country-wise Adult and Pediatric Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Adult and Pediatric Vaccines Consumption Forecast (2022-2028)

    9 Global Adult and Pediatric Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Adult and Pediatric Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Adult Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Adult and Pediatric Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Care Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Adult and Pediatric Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Adult and Pediatric Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Adult and Pediatric Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Medical Care Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Adult and Pediatric Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Adult and Pediatric Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Adult and Pediatric Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Adult and Pediatric Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Adult and Pediatric Vaccines Market Competitive Analysis

    • 14.1 Emergent BioSolutions, Inc (US)

      • 14.1.1 Emergent BioSolutions, Inc (US) Company Details

      • 14.1.2 Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Product and Service

    • 14.2 Mitsubishi Tanabe Pharma Corporation (Japan),

      • 14.2.1 Mitsubishi Tanabe Pharma Corporation (Japan), Company Details

      • 14.2.2 Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Product and Service

    • 14.3 GlaxoSmithKline plc (UK)

      • 14.3.1 GlaxoSmithKline plc (UK) Company Details

      • 14.3.2 GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Product and Service

    • 14.4 Daiichi Sankyo Company, Limited (Japan)

      • 14.4.1 Daiichi Sankyo Company, Limited (Japan) Company Details

      • 14.4.2 Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Product and Service

    • 14.5 Serum Institute of India Pvt Ltd (India)

      • 14.5.1 Serum Institute of India Pvt Ltd (India) Company Details

      • 14.5.2 Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Product and Service

    • 14.6 Pfizer, Inc (US)

      • 14.6.1 Pfizer, Inc (US) Company Details

      • 14.6.2 Pfizer, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer, Inc (US) Adult and Pediatric Vaccines Product and Service

    • 14.7 Bavarian Nordic (Denmark)

      • 14.7.1 Bavarian Nordic (Denmark) Company Details

      • 14.7.2 Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Product and Service

    • 14.8 Merck & Co, Inc (US)

      • 14.8.1 Merck & Co, Inc (US) Company Details

      • 14.8.2 Merck & Co, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck & Co, Inc (US) Adult and Pediatric Vaccines Product and Service

    • 14.9 Johnson & Johnson (US)

      • 14.9.1 Johnson & Johnson (US) Company Details

      • 14.9.2 Johnson & Johnson (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson (US) Adult and Pediatric Vaccines Product and Service

    • 14.10 CSL Limited (Australia)

      • 14.10.1 CSL Limited (Australia) Company Details

      • 14.10.2 CSL Limited (Australia) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CSL Limited (Australia) Adult and Pediatric Vaccines Product and Service

    • 14.11 Sanofi Pasteur (France)

      • 14.11.1 Sanofi Pasteur (France) Company Details

      • 14.11.2 Sanofi Pasteur (France) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Sanofi Pasteur (France) Adult and Pediatric Vaccines Product and Service

    • 14.12 AstraZeneca (UK)

      • 14.12.1 AstraZeneca (UK) Company Details

      • 14.12.2 AstraZeneca (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AstraZeneca (UK) Adult and Pediatric Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Adult and Pediatric Vaccines

    • Figure Adult and Pediatric Vaccines Picture

    • Table Global Adult and Pediatric Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Adult and Pediatric Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Adult and Pediatric Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Adult and Pediatric Vaccines Consumption by Country (2017-2022)

    • Figure United States Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Adult and Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Adult and Pediatric Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Adult and Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Care Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Care Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Adult and Pediatric Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Adult and Pediatric Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Emergent BioSolutions, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions, Inc (US) Adult and Pediatric Vaccines Product and Service

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Corporation (Japan), Adult and Pediatric Vaccines Product and Service

    • Table GlaxoSmithKline plc (UK) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Adult and Pediatric Vaccines Product and Service

    • Table Daiichi Sankyo Company, Limited (Japan) (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company, Limited (Japan) Adult and Pediatric Vaccines Product and Service

    • Table Serum Institute of India Pvt Ltd (India) (Foundation Year, Company Profile and etc.)

    • Table Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd (India) Adult and Pediatric Vaccines Product and Service

    • Table Pfizer, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc (US) Adult and Pediatric Vaccines Product and Service

    • Table Bavarian Nordic (Denmark) (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic (Denmark) Adult and Pediatric Vaccines Product and Service

    • Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Adult and Pediatric Vaccines Product and Service

    • Table Johnson & Johnson (US) (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson (US) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson (US) Adult and Pediatric Vaccines Product and Service

    • Table CSL Limited (Australia) (Foundation Year, Company Profile and etc.)

    • Table CSL Limited (Australia) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited (Australia) Adult and Pediatric Vaccines Product and Service

    • Table Sanofi Pasteur (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur (France) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur (France) Adult and Pediatric Vaccines Product and Service

    • Table AstraZeneca (UK) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca (UK) Adult and Pediatric Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca (UK) Adult and Pediatric Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US